BIF acquires shares in Avasa

Page 1 of 1



11 July 2022
Booster Innovation Fund adds Avasa to its investment portfolio

Booster is pleased to announce the addition of Avasa to the Booster Innovation Fund (BIF) portfolio.

Avasa operates in the medical device part of the life sciences and medical technologies sector. It
specialises in the development of a unique medical device aiding in complex artery and vein
reconstruction. It was formed in 2018, and is classified as seed stage, with its technology first backed by
the University of Auckland.

BIF will make a cash investment of $150,000. Following this transaction (and issue of additional units to
fund the purchase), Avasa will represent 1.0% of BIF’s investment portfolio of 34 companies, and with a
net asset value of over $15m.

Investors can continue to purchase units in BIF on the NZX or can subscribe for units in the fund as part of
the process described in the fund’s Product Disclosure Statement (PDS) that is available at
www.booster.co.nz

For further information regarding BIF visit https://www.booster.co.nz/booster-investments/booster-
innovation-fund.aspx





For more information, please contact:
Gary Scott
Company Secretary
Booster Investment Management Limited
04 8944300


About Booster
Booster Investment Management Limited (Booster) is the manager and issuer of the Fund, and part of
the Booster Group which has been helping New Zealanders save since 1998. The group currently
administers superannuation and investment funds of over $5 billion on behalf of more than 190,000 New
Zealanders.
BIF is a managed investment fund that invests in early-stage companies founded on intellectual property
originated or developed in New Zealand.
For more information, including a copy of the Product Disclosure Statement, please visit
www.booster.co.nz